Top compounds associated with response to AKT2


Feature Type Standardized
Nominal ANOVA
mRNA Bax channel blocker CTRPv2 pan-cancer AAC 0.12 0.002
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 0.002
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.002
mRNA PL-DI CTRPv2 pan-cancer AAC 0.095 0.002
mRNA blebbistatin CTRPv2 pan-cancer AAC 0.22 0.003
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.098 0.003
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA KU-60019 CTRPv2 pan-cancer AAC 0.1 0.003
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.099 0.004
Download CSV